The record
| Class | healing |
|---|---|
| Also known as | - |
| Chain length | - |
| Molecular weight | 889.0 Da |
| Half-life | 7-10 days |
| Route | - |
| Studied for | - |
| Research use | - |
| What has been shown | - |
| How it works | Actin sequestration; Cell migration; Angiogenesis; Stem cell differentiation |
| Patent status | - |
| Regulatory status | - |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Joint / Tendon Healing (affection, 47%)
- Muscle Recovery (affection, 51%)
- Wound Healing / Tissue Repair (affection, 60%)
- Skin Regeneration / Aesthetic Healing (affection, 42%)
- GI Inflammation Modulation (affection, 36%)
- Inflammation Modulation (affection, 38%)
- Bone Health / Remodeling Support (affection, 31%)
- Anti-fibrotic Signaling Environment (affection, 48%)
- Androgenetic alopecia (illness, 40%)
- Anti-biofilm treatment (illness, 45%)
- Antimicrobial applications (illness, 45%)
- Cancer immunotherapy adjuvant (illness, 30%)
- Cardiac repair (illness, 60%)
- Corneal injuries/dry eye (illness, 60%)
- COVID-19 (illness, 30%)
- Hair follicle regeneration (illness, 40%)
- Hepatitis B/C treatment (illness, 30%)
- Immunomodulation (illness, 45%)
- Neurotrophic keratopathy (illness, 60%)
- Scar reduction (illness, 40%)
- Sepsis treatment (illness, 30%)
- Sepsis/endotoxemia protection (illness, 45%)
- Vaccine adjuvant (illness, 30%)
- Wound healing (illness, 52%)
- Wound healing enhancement (illness, 40%)
- Pain (symptom, 50%)
- Slow healing of an injury (symptom, 75%)
- Muscle loss or weakness (symptom, 33%)
- Frequent infections (symptom, 50%)